Improved metabolic control in diabetes, HSP60, and proinflammatory mediators

Autoimmune Diseases

Volumn 1, Issue 1, 2012, Pages

  Blasi, Claudio ^a   Kim, Eunjung ^b   Knowlton, Anne A ^c  

^a ASL Roma B   (Italy)

^b Daejeon Catholic University Hospital   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; GLICLAZIDE; HEAT SHOCK PROTEIN 60; HEMOGLOBIN A1C; HSP60 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; METFORMIN; REPAGLINIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTI HSP60 ANTIBODY; CHAPERONIN 60; CYTOKINE; GLIMEPIRIDE PLUS METFORMIN; INTERLEUKIN 1BETA; METFORMIN PLUS REPAGLINIDE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HUMAN; HYPOTHESIS; ITALY; MALE; METABOLIC REGULATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; AGED; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; INTENSIVE CARE;

EID: 84874907046     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2012/346501     Document Type: Article

References (39)

1. Xu J., Zou M. H., Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 2009 120 13 1266 1286 2-s2.0-70349675632 10.1161/CIRCULATIONAHA.108.835223
2. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485
3. Tabit C. E., Chung W. B., Hamburg N. M., Vita J. A., Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Reviews in Endocrine and Metabolic Disorders 2010 11 1 61 74 2-s2.0-77953393648 10.1007/s11154-010-9134-4
4. Punthakee Z., Werstuck G. H., Gerstein H. C., Diabetes and cardiovascular disease: explaining the relationship. Reviews in Cardiovascular Medicine 2007 8 3 145 153 2-s2.0-34848903305
5. Kelly T. N., Bazzano L. A., Fonseca V. A., Thethi T. K., Reynolds K., He J., Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Annals of Internal Medicine 2009 151 6 394 403 2-s2.0-70349124205
6. Skyler J. S., Bergenstal R., Bonow R. O., Buse J., Deedwania P., Gale E. A. M., Howard B. V., Kirkman M. S., Kosiborod M., Reaven P., Sherwin R. S., Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials. Circulation 2009 119 2 351 357 2-s2.0-59849090453 10.1161/CIRCULATIONAHA.108.191305
7. Bakker W., Eringa E. C., Sipkema P., van Hinsbergh V. W. M., Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell and Tissue Research 2009 335 1 165 189 2-s2.0-57749177096 10.1007/s00441-008-0685-6
8. Lamb R. E., Goldstein B. J., Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. International Journal of Clinical Practice 2008 62 7 1087 1095 2-s2.0-44849100216 10.1111/j.1742-1241.2008.01789.x
9. Blasi C., The autoimmune origin of atherosclerosis. Atherosclerosis 2008 201 1 17 32 2-s2.0-53849105417 10.1016/j.atherosclerosis.2008.05.025
10. Pfister G., Stroh C. M., Perschinka H., Kind M., Knoflach M., Hinterdorfer P., Wick G., Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. Journal of Cell Science 2005 118 8 1587 1594 2-s2.0-18844369636 10.1242/jcs.02292
11. Stice J. P., Chen L., Kim S. C., Jung J. S., Tran A. L., Liu T. T., Knowlton A. A., 17 β -estradiol, aging, inflammation, and the stress response in the female heart. Endocrinology 2011 152 4 1589 1598 2-s2.0-79953166042 10.1210/en.2010-0627
12. Sitia S., Tomasoni L., Atzeni F., Ambrosio G., Cordiano C., Catapano A., Tramontana S., Perticone F., Naccarato P., Camici P., Picano E., Cortigiani L., Bevilacqua M., Milazzo L., Cusi D., Barlassina C., Sarzi-Puttini P., Turiel M., From endothelial dysfunction to atherosclerosis. Autoimmunity Reviews 2010 9 12 830 834 2-s2.0-77956934512 10.1016/j.autrev.2010.07.016
13. Wick G., Knoflach M., Xu Q., Autoimmune and inflammatory mechanisms in atherosclerosis. Annual Review of Immunology 2004 22 361 403 2-s2.0-2542498855 10.1146/annurev.immunol.22.012703.104644
14. Gupta S., Knowlton A. A., Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002 106 21 2727 2733 2-s2.0-0037137296 10.1161/01.CIR.0000038112.64503.6E
15. Shamaei-Tousi A., Stephens J. W., Bin R., Cooper J. A., Steptoe A., Coates A. R. M., Henderson B., Humphries S. E., Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. European Heart Journal 2006 27 13 1565 1570 2-s2.0-33745444246 10.1093/eurheartj/ehl081
16. Lin L., Kim S. C., Wang Y., Gupta S., Davis B., Simon S. I., Torre-Amione G., Knowlton A. A., HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. American Journal of Physiology 2007 293 4 H2238 H2247 2-s2.0-35348932656 10.1152/ajpheart.00740.2007
17. Wang Y., Chen L., Hagiwara N., Knowlton A. A., Regulation of heat shock protein 60 and 72 expression in the failing heart. Journal of Molecular and Cellular Cardiology 2010 48 2 360 366 2-s2.0-74249089970 10.1016/j.yjmcc.2009. 11.009
18. Kol A., Bourcier T., Lichtman A. H., Libby P., Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. Journal of Clinical Investigation 1999 103 4 571 577 2-s2.0-0033557202
19. Li J., Jin C., Cleveland J. C. Jr., Ao L., Xu D., Fullerton D. A., Meng X., Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin. Cardiovascular Diabetology 2010 9, article 90 2-s2.0-78650137830 10.1186/1475-2840-9-90
20. Dasu M. R., Jialal I., Free fatty acids in the presence of high glucose amplify monocyte inflammation via toll-like receptors. American Journal of Physiology 2011 300 1 E145 E154 2-s2.0-78650773537 10.1152/ajpendo.00490.2010
21. Kim S. C., Stice J. P., Chen L., Jung J. S., Gupta S., Wang Y., Baumgarten G., Trial J., Knowlton A. A., Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circulation Research 2009 105 12 1186 1195 2-s2.0-73349130785 10.1161/CIRCRESAHA.109.209643
22. Kol A., Sukhova G. K., Lichtman A. H., Libby P., Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor- α and matrix metalloproteinase expression. Circulation 1998 98 4 300 307 2-s2.0-0032575305
23. Zhu J., Quyyumi A. A., Rott D., Csako G., Wu H., Halcox J., Epstein S. E., Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001 103 8 1071 1075 2-s2.0-0035957031
24. Mol M. J. T. M., de Rijke Y. B., Demacker P. N. M., Stalenhoef A. F. H., Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 1997 129 2 169 176 2-s2.0-0030904025 10.1016/S0021-9150(96) 06022-4
25. Adachi T., Inoue M., Hara H., Maehata E., Suzuki S., Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. Journal of Endocrinology 2004 181 3 413 417 2-s2.0-3042847386 10.1677/joe.0.1810413
26. Doganay S., Evereklioglu C., Er H., Türköz Y., Sevinç A., Mehmet N., Şavli H., Comparison of serum NO, TNF- α IL-1 β sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002 16 2 163 170 2-s2.0-0035984887 10.1038/sj.EYE. 6700095
27. Lee J. H., Lee W., Oh H. K., Kim J. H., Kwon O. W., Kyung H. K., Lim J. B., Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Annals of Clinical and Laboratory Science 2008 38 4 361 367 2-s2.0-55949126170
28. Mishra M., Kumar H., Bajpai S., Singh R. K., Tripathi K., Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Research and Clinical Practice 2011 94 2 255 261 2-s2.0-81255157815 10.1016/j.diabres.2011.07.037
29. McGee K. C., Harte A. L., da Silva N. F., Al-Daghri N., Creely S. J., Kusminski C. M., Tripathi G., Levick P. L., Khanolkar M., Evans M., Chittari M. V., Patel V., Kumar S., McTernan P. G., Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NF κ B and JNK in human abdominal subcutaneous adipocytes. PLoS ONE 2011 6 6 2-s2.0-79958255699 10.1371/journal.pone.0020287 e20287
30. Park J. S., Cho M. H., Nam J. S., Yoo J. S., Ahn C. W., Cha B. S., Kim K. R., Lee H. C., Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. European Journal of Endocrinology 2011 164 1 69 74 2-s2.0-78751479361 10.1530/EJE-10-0875
31. Hu Y., Tong G., Xu W., Pan J., Ryan K., Yang R., Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis. Diabetes and Vascular Disease Research 2009 6 4 262 268 2-s2.0-70350163405 10.1177/1479164109339966
32. Ozturk B. T., Bozkurt B., Kerimoglu H., Okka M., Kamis U., Gunduz K., Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Molecular Vision 2009 15 1906 1914 2-s2.0-70349609915
33. Ellins E., Shamaei-Tousi A., Steptoe A., Donald A., O'Meagher S., Halcox J., Henderson B., The relationship between carotid stiffness and circulating levels of heat shock protein 60 in middle-aged men and women. Journal of Hypertension 2008 26 12 2389 2392 2-s2.0-59849109100 10.1097/HJH. 0b013e328313918b
34. Knoflach M., Kiechl S., Kind M., Said M., Sief R., Gisinger M., van der Zee R., Gaston H., Jarosch E., Willeit J., Wick G., Cardiovascular risk factors and atherosclerosis in young males: ARMY study (atherosclerosis risk-factors in male youngsters). Circulation 2003 108 9 1064 1069 2-s2.0-0042818096 10.1161/01.CIR.0000085996.95532.FF
35. Schett G., Xu Q., Amberger A., van der Zee R., Recheis H., Willeit J., Wick G., Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. Journal of Clinical Investigation 1995 96 6 2569 2577 2-s2.0-0028809489
36. Dieudé M., Senécal J. L., Raymond Y., Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis and Rheumatism 2004 50 10 3221 3231 2-s2.0-5644291914 10.1002/art.20564
37. Moohebati M., Bidmeshgi S., Azarpazhooh M. R., Daloee M. H., Ghayour-Mobarhan M., Tavallaie S., Amini M., Momenzadeh A., Sahebkar A., Paydar R., Rahsepar A. A., Parizadeh S. M. R., Akhlaghi S., Ferns G. A. A., Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: a randomized, double-blind, placebo-controlled, cross-over trial. Clinical Biochemistry 2011 44 2-3 192 197 2-s2.0-79151476825 10.1016/j.clinbiochem.2010.09.016
38. Spite M., Serhan C. N., Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins. Circulation Research 2010 107 10 1170 1184 2-s2.0-78549283981 10.1161/CIRCRESAHA.110.223883
39. Marsland A. L., McCaffery J. M., Muldoon M. F., Manuck S. B., Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 2010 59 12 1801 1808 2-s2.0-78549245105 10.1016/j.metabol.2010.05.015